Thyroid Eye Disease: Unmasking and Taming What’s in Disguise
This activity is supported by educational funding provided by Amgen.
Already read the print version?
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by educational funding provided by Amgen.
Activity Description
Thyroid eye disease (TED) is a complex autoimmune-mediated inflammatory disorder of the orbit that is associated with a spectrum of signs and symptoms and varying levels of severity. Early diagnosis and initiation of appropriate treatment are imperative for preventing progression to severe disease and potential vision loss; however, diagnosis can be challenging. Traditional treatments for TED, such as steroids, radiotherapy, and surgery, all relieve symptoms but do not alter the course of disease. Newly approved and emerging monoclonal antibodies targeting the insulin-like growth factor-1 receptor have demonstrated efficacy in the management of TED, including for patients with low clinical activity scores, resulting in a paradigm shift in disease management. In this CE monograph, experts in the field evaluate treatment strategies that exhibit a favorable risk-benefit profile to improve outcomes and patient satisfaction and review risk factors and classification criteria that aid in the timely differential diagnosis of TED. Challenging real-world cases that allow for application of the content into clinical practice are presented.
Target Audience
The intended audience for this activity is comprehensive ophthalmologists and other healthcare professionals involved in the management of patients with TED.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Recognize TED as a chronic autoimmune disease that may flare, regardless of treatment.
- Differentially diagnose TED to facilitate early treatment.
- Incorporate treatment strategies for TED that exhibit a favorable benefit-risk profile to improve outcomes and patient satisfaction.
Activity Chair
Andrea Lora Kossler, MD, FACS
Director, Oculofacial Plastic and Orbital Surgery
Associate Professor of Ophthalmology
Byers Eye Institute at Stanford University School of Medicine
Palo Alto, CA
Faculty
Jennifer M. Loh, MD
Medical Director, Loh Ophthalmology Associates
Board Member, Eye Physicians of Florida
Clinical Faculty, Larkin Hospital Ophthalmology Residency
Miami, FL
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Medical Writer
Valerie Zimmerman, PhD
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, September 25, 2024, to September 25, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Kossler and Loh during a live meeting held on June 1, 2024. The monograph has been approved by both faculty individually as an accurate representation of their presentations.
Activity Chair and Faculty report the following relevant financial relationship(s)
Andrea Lora Kossler, MD, FACS
Consultant: Acelyrin, Amgen/Horizon, Argenx, Immunovant, Genentech, Kriya, Lassen, Viridian
Independent Research Contractor: Amgen/Horizon, Lassen, Sling, Viridian
Jennifer M. Loh, MD
Consultant: AbbVie, Alcon, Amgen/Horizon, Bausch + Lomb, BVI, Centricity, Dompé, Johnson & Johnson Vision, LENSAR, NovaBay, Ocular Science, Orasis, Oyster Point, Sight Sciences, Sun, Tarsus, Vialase, Visus, Zeiss
Speaker Contracted by Ineligible Company: AbbVie, Alcon, Bausch + Lomb, Sight Sciences, Sun
Independent Research Contractor: Sight Sciences
Stock Options: Ocular Science
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Medical Writer reports the following relevant financial relationship(s)
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com